http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5598196-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36baf8f31555cb0e8efac3c099a57364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_806aa4aad97e6ec01803b896bfd9543e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-83
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
filingDate 1979-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffb976b957ecdc1cedd424412e2681fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5701abc63146cd1475867a5f95f99264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b699d7b7e6ca5e9b4c6a101cf4471120
publicationDate 1980-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5598196-A
titleOfInvention Fractionation of fibrinogen or its constituents and their use
abstract PURPOSE: To obtain fibrinogen or its fractionated constituents 1 and 2 quantitatively, by bringing a fibrinogen-containing composition into contact with an amino carboxylic acid in the presence of an ionic strength adjustor in an aqueous medium. n CONSTITUTION: A fibrinogen-containing composition, e.g. blood plasma, is brought into contact with an amino-carboxylic acid, e.g. glycine, of the formla (n is a positive integer, preferably 1W3) in the presence of an inonic strength adjustor, e.g. sodium chloride, in an aqueous medium to isolate the fibrinogen or its constituents 1 or 2 separately in high purity. The quantitative isolation is useful for diseases induced from abnormal blood coagulation, e.g. hemorrhagic diseases, thrombosis, and D1C syndrome (intravascular coagulation syndrome) and diagnosis on liver diseases. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4833409-B2
priorityDate 1979-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474406
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5467
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 33.